Online Only Articles

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma

University of Chicago, Chicago, IL, USA;University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA;Karol Marcinkowski University of Medical Sciences, Poznan, Poland
University of Chicago, Chicago, IL, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
The John Theurer Cancer Center at Hackensack UMC, Hackensack, NJ, USA
Mount Sinai Medical Center, New York, NY, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Washington University School of Medicine, St. Louis, MO, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Chicago, Chicago, IL, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Washington University School of Medicine, St. Louis, MO, USA
University of Chicago, Chicago, IL, USA;University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA
Vol. 99 No. 9 (2014): September, 2014 https://doi.org/10.3324/haematol.2014.110395